For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
UiPath Inc (NYSE: PATH) closed the day trading at $9.97 down -15.72% from the previous closing price of $11.83. In other words, the price has decreased by -$15.72 from its previous closing price. On the day, 49.43 million shares were traded. PATH stock price reached its highest trading level at $10.33 during the session, while it also had its lowest trading level at $9.5.
Ratios:
For a better understanding of PATH, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 3.36 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 17.93. For the most recent quarter (mrq), Quick Ratio is recorded 3.01 and its Current Ratio is at 2.82. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.04.
Macquarie Downgraded its Outperform to Neutral on June 03, 2024, whereas the target price for the stock was revised from $29 to $12.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Feb 25 ’25 when Ramani Hitesh sold 12,500 shares for $12.68 per share. The transaction valued at 158,449 led to the insider holds 256,921 shares of the business.
HITESH RAMANI bought 12,500 shares of PATH for $165,500 on Feb 25 ’25. On Jan 03 ’25, another insider, Ramani Hitesh, who serves as the Chief Accounting Officer of the company, sold 25,000 shares for $13.05 each. As a result, the insider received 326,162 and left with 269,421 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PATH now has a Market Capitalization of 5479501824 and an Enterprise Value of 3937663488. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.83 while its Price-to-Book (P/B) ratio in mrq is 3.16. Its current Enterprise Value per Revenue stands at 2.754 whereas that against EBITDA is -27.093.
Stock Price History:
The Beta on a monthly basis for PATH is 0.96, which has changed by -0.5617583 over the last 52 weeks, in comparison to a change of 0.07903516 over the same period for the S&P500. Over the past 52 weeks, PATH has reached a high of $25.47, while it has fallen to a 52-week low of $10.37. The 50-Day Moving Average of the stock is -25.28%, while the 200-Day Moving Average is calculated to be -22.64%.
Shares Statistics:
Over the past 3-months, PATH traded about 9.01M shares per day on average, while over the past 10 days, PATH traded about 16838890 shares per day. A total of 549.60M shares are outstanding, with a floating share count of 415.49M. Insiders hold about 24.40% of the company’s shares, while institutions hold 52.79% stake in the company. Shares short for PATH as of 1740700800 were 33563297 with a Short Ratio of 3.72, compared to 1738281600 on 31851059. Therefore, it implies a Short% of Shares Outstanding of 33563297 and a Short% of Float of 7.920000000000001.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
The market rating for UiPath Inc (PATH) is a result of the insights provided by 18.0 analysts actively involved in the assessment.The consensus estimate for the next quarter is $0.07, with high estimates of $0.14 and low estimates of $0.03.
Analysts are recommending an EPS of between $0.6 and $0.47 for the fiscal current year, implying an average EPS of $0.54. EPS for the following year is $0.59, with 21.0 analysts recommending between $0.66 and $0.44.
Revenue Estimates
17 analysts predict $332.82M in revenue for the current quarter. It ranges from a high estimate of $335M to a low estimate of $331.2M. As of the current estimate, UiPath Inc’s year-ago sales were $335.11MFor the next quarter, 17 analysts are estimating revenue of $332.48M. There is a high estimate of $334.7M for the next quarter, whereas the lowest estimate is $331.1M.
A total of 22 analysts have provided revenue estimates for PATH’s current fiscal year. The highest revenue estimate was $1.59B, while the lowest revenue estimate was $1.53B, resulting in an average revenue estimate of $1.54B. In the same quarter a year ago, actual revenue was $1.43BBased on 21 analysts’ estimates, the company’s revenue will be $1.67B in the next fiscal year. The high estimate is $1.76B and the low estimate is $1.63B.
